Capricor Therapeutics
CAPR
#6981
Rank
โ‚ฌ0.37 B
Marketcap
8,26ย โ‚ฌ
Share price
-2.27%
Change (1 day)
33.68%
Change (1 year)

Revenue for Capricor Therapeutics (CAPR)

Revenue in 2024 (TTM): โ‚ฌ20.96 Million

According to Capricor Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ20.31 Million. a decrease over the revenue in the year 2023 that were of โ‚ฌ22.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Capricor Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ21.4 M-6.04%
2023 โ‚ฌ22.77 M857.54%
2022 โ‚ฌ2.37 M999.96%
2021 โ‚ฌ0.21 M-14.27%
2020 โ‚ฌ0.25 M-71.88%
2019 โ‚ฌ0.89 M-38.59%
2018 โ‚ฌ1.46 M-19.98%
2017 โ‚ฌ1.82 M-39.8%
2016 โ‚ฌ3.03 M-12.18%
2015 โ‚ฌ3.45 M0.8%
2014 โ‚ฌ3.42 M
2013 N/A-100%
2012 โ‚ฌ0.14 M-85.83%
2011 โ‚ฌ1.04 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ16.85 M-17.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.31 M-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ81.02 B 398,728.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.14 B 10,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.4 M-68.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.53 M-97.39%๐Ÿ‡บ๐Ÿ‡ธ USA